*Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada; †Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada; ‡Department of Oncology, Saint John Regional Hospital, Saint John, New Brunswick, Canada; §Department of Radiation Oncology, British Columbia Cancer Agency Fraser Valley Centre, Surrey, British Columbia, Canada; ‖Department of Radiation Oncology, British Columbia Cancer Agency Vancouver Island Centre, Victoria, British Columbia, Canada; ¶Department of Radiation Oncology, Cancer Care Manitoba, Winnipeg, Manitoba, Canada; and #British Columbia Cancer Agency Centre for the North, Prince George, British Columbia, Canada.
J Thorac Oncol. 2014 Apr;9(4):527-33. doi: 10.1097/JTO.0000000000000119.
Although the value of peer review is increasingly recognized, there is little research documenting its impact in the setting of stereotactic body radiation therapy (SBRT) for lung cancer. This study determines the dosimetric effect of peer review of tumor and normal tissue contouring in lung SBRT planning.
Forty anonymized lung SBRT plans were retrospectively evaluated post treatment. Each plan was independently reviewed by two to three radiation oncologists using established institutional guidelines. For each structure, reviewers recorded recommendations for "no change," "minor change," "major change," or "missing contour" and provided a modified or new contour as needed. Dose-volume histograms were analyzed for dosimetric violations.
Among 472 contoured structures evaluated, recommendations from peer review were 107 major change (23%), 176 minor change (37%), 157 no change (33%), and 32 missing (7%). Common major changes involved the skin (n = 20), heart (n = 18), and proximal bronchial tree (n = 15). Dose constraints were not achieved for 25 new or recontoured structures (5%), of which 17 involved the planning target volume (PTV). Among cases with PTV violations, the mean prescription dose coverage to the modified PTVs was 90%, compared with the protocol standard of greater than or equal to 95% coverage. The remaining violations involved the ribs (n = 5), spinal canal (n = 2), and heart (n = 1).
Peer review of structure contouring resulted in significant changes in lung SBRT plans. Recontouring of several plans revealed violations of dose limits, most often involving inadequate PTV coverage. Peer review, especially of target volume delineation, is warranted to improve consistency and quality in lung SBRT planning.
尽管同行评议的价值越来越受到认可,但在立体定向体放射治疗(SBRT)治疗肺癌的背景下,关于其影响的研究却很少。本研究旨在确定肺癌 SBRT 计划中肿瘤和正常组织勾画的同行评议对剂量学的影响。
回顾性评估了 40 例匿名的肺癌 SBRT 计划。每个计划都由 2 至 3 名放射肿瘤学家使用既定的机构指南进行独立审查。对于每个结构,审查员记录了“无需更改”、“微小更改”、“重大更改”或“缺少轮廓”的建议,并根据需要提供了修改或新的轮廓。分析剂量体积直方图以评估剂量学违规情况。
在评估的 472 个勾画结构中,同行评议的建议包括 107 个重大更改(23%)、176 个微小更改(37%)、157 个无需更改(33%)和 32 个缺失(7%)。常见的重大更改涉及皮肤(n = 20)、心脏(n = 18)和近端支气管树(n = 15)。25 个新或重新勾画的结构未达到剂量限制(5%),其中 17 个涉及计划靶区(PTV)。在存在 PTV 违规的情况下,修改后的 PTV 的处方剂量覆盖率平均为 90%,而协议标准为大于或等于 95%的覆盖率。其余违规涉及肋骨(n = 5)、椎管(n = 2)和心脏(n = 1)。
结构勾画的同行评议导致肺癌 SBRT 计划发生重大变化。对几个计划进行重新勾画揭示了剂量限制的违规情况,最常见的是 PTV 覆盖不足。需要进行同行评议,特别是对靶区勾画进行评议,以提高肺癌 SBRT 计划的一致性和质量。